Signaling pathways
-
BA8683 K-80003Summary: Effectively inhibits tRXRα-dependent activation and tumor cell growth. -
BA8684 AKT-IN-1Summary: AKT-IN-1 is a metastable inhibitor. -
BA8686 FluorofenidoneSummary: Fluorofenidone (AKF-PD), an analog of AMR69, has equivalent antifibrotic activity but lower toxicity and longer half-life. -
BA8687 TASP0415914Summary: TASP0415914 is a potent and orally active inhibitor. -
BA8688 AKT-IN-20Summary: AKT-IN-20 is an inhibitor. -
BA8689 BRD0705Summary: BRD0705 is a potent, paracrine-selective and orally active inhibitor. -
BA8690 KY19382Summary: KY19382 is a potent and orally active dual inhibitor. -
BA8691 PF-04802367Summary: PF-04802367 (PF-367) is a highly selective inhibitor. -
BA8692 SAR502250Summary: SAR502250 is a potent, selective, ATP-competitive, orally active and blood-brain barrier-crossing inhibitor. -
BA8693 GNF4877Summary: GNF4877 is a potent inhibitor.

